Skip to main content

Lam Research Corporation (LRCX)

Stock NASDAQ

$210.69

-6.41 (-3.04%)

Delayed quote.

Price history

Daily close
LRCX daily closing price, Nov 18, 2025 to Nov 17, 2026 Closed at $143.24 on Nov 18, 2025 and $210.69 on Nov 17, 2026, a change of +47.09%. Range $139.59 to $433.33.
Daily closes, Nov 18, 2025 to Nov 17, 2026 (251 trading days).
Start
$143.24
Latest close
$210.69
Period change
+47.09%
Period low
$139.59
Period high
$433.33

Key metrics

Market cap
$255.36B
Volume
1.82M
Average volume
10.36M
52-week range
$135.50 – $438.50
Beta
2.01
Last dividend
$1.11
EPS (TTM)
$6.75
P/E ratio
31.21
Revenue (TTM)
$26.13B
Net income (TTM)
$8.45B
Total assets
$26.35B
Total debt
$3.74B
Cash and equivalents
$7.44B

Key financials (trailing twelve months).

Company profile

Lam Research Corporation is a prominent supplier of equipment vital for semiconductor processing, encompassing its design, production, sales, repair, and ongoing maintenance. These sophisticated systems are fundamental for the creation of integrated circuits. The company's extensive product catalog features a variety of deposition technologies. For tungsten metallization, they provide ALTUS systems that deposit conformal films. SABRE products excel in electrochemical deposition, crucial for copper interconnect transitions and enabling copper damascene manufacturing. SOLA utilizes ultraviolet thermal processing for film treatments, while VECTOR delivers plasma-enhanced chemical vapor deposition (CVD) and atomic layer deposition (ALD) solutions. Furthermore, SPEED addresses gapfill applications with its high-density plasma CVD products, and Striker is engineered for single-wafer atomic layer deposition of dielectric films. Beyond deposition, Lam Research offers a comprehensive suite of etching tools. Flex is designed for dielectric etch applications, Kiyo handles conductor etch processes, Syndion specializes in through-silicon via etching, and Versys metal products are used for metal etch processes. The company's offerings also extend to specialized solutions like Coronus, which enhances die yield through bevel cleaning. For various wafer cleaning requirements, Lam Research supplies multiple product lines, including Da Vinci, DV-Prime, EOS, and SP series. Additionally, Metryx mass metrology systems provide precise, in-line mass measurement capabilities for semiconductor wafer manufacturing. Lam Research serves the global semiconductor industry, distributing its technologies and services across the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and other international markets. Established in 1980, the company maintains its corporate headquarters in Fremont, California.

Sector
Technology
Industry
Semiconductors
Exchange
NASDAQ
CEO
Timothy Archer
Employees
24,300
Headquarters
Fremont, CA, US
IPO date
1984-05-04

Financial statements

Annual, last 3 fiscal years. Most recent period first. Reported in USD.

Income statement
MetricFY2026Jun 28, 2026FY2025Jun 29, 2025FY2024Jun 30, 2024
Revenue$23.23B$18.44B$14.91B
Gross profit$11.73B$8.98B$7.05B
Operating income$8.20B$5.90B$4.26B
EBITDA$8.70B$6.34B$4.91B
Net income$7.27B$5.36B$3.83B
Diluted EPS$5.76$4.15$2.90
Balance sheet
MetricFY2026Jun 28, 2026FY2025Jun 29, 2025FY2024Jun 30, 2024
Cash and equivalents$5.58B$6.39B$5.85B
Total assets$23.53B$21.35B$18.74B
Total liabilities$11.06B$11.48B$10.21B
Total debt$4.12B$4.76B$4.98B
Shareholders’ equity$12.47B$9.86B$8.54B
Cash flow statement
MetricFY2026Jun 28, 2026FY2025Jun 29, 2025FY2024Jun 30, 2024
Operating cash flow$5.86B$6.17B$4.65B
Capital expenditure-$966.40M-$759.19M-$396.67M
Free cash flow$4.89B$5.41B$4.26B

Quarterly, last 6 quarters. Most recent period first. Reported in USD.

Income statement
MetricQ1 2027Sep 27, 2026Q4 2026Jun 28, 2026Q3 2026Mar 29, 2026Q2 2026Dec 28, 2025Q1 2026Sep 28, 2025Q4 2025Jun 29, 2025
Revenue$8.22B$6.72B$5.84B$5.34B$5.32B$5.17B
Gross profit$4.30B$3.48B$2.91B$2.65B$2.68B$2.59B
Operating income$3.28B$2.51B$2.05B$1.81B$1.83B$1.74B
EBITDA$3.43B$2.59B$2.17B$1.98B$1.96B$1.88B
Net income$2.75B$2.28B$1.83B$1.59B$1.57B$1.72B
Diluted EPS$2.19$1.81$1.45$1.26$1.24$1.35
Balance sheet
MetricQ1 2027Sep 27, 2026Q4 2026Jun 28, 2026Q3 2026Mar 29, 2026Q2 2026Dec 28, 2025Q1 2026Sep 28, 2025Q4 2025Jun 29, 2025
Cash and equivalents$7.44B$5.58B$4.75B$6.18B$6.69B$6.39B
Total assets$26.35B$23.53B$20.79B$21.39B$21.90B$21.35B
Total liabilities$12.44B$11.06B$10.21B$11.25B$11.71B$11.48B
Total debt$3.74B$4.12B$3.73B$4.48B$4.48B$4.48B
Shareholders’ equity$13.91B$12.47B$10.58B$10.15B$10.19B$9.86B
Cash flow statement
MetricQ1 2027Sep 27, 2026Q4 2026Jun 28, 2026Q3 2026Mar 29, 2026Q2 2026Dec 28, 2025Q1 2026Sep 28, 2025Q4 2025Jun 29, 2025
Operating cash flow$3.50B$1.46B$1.14B$1.48B$1.78B$2.55B
Capital expenditure-$257.70M-$188.80M-$331.60M-$260.88M-$185.12M-$172.19M
Free cash flow$3.24B$1.27B$809.82M$1.22B$1.59B$2.38B